Search research articles
Contact Us
Filters
Showing results (51-60 of 118) with videos related to
Page
of 12
Sort By:
Leukemia & Lymphoma
|
October 8, 2025
Clinical and radiological prediction models for random skin biopsy positivity in suspected intravascular large B-cell lymphoma: development and internal validation
Hajime Sakuma, Kentaro Narita, Rikako Tabata, et al.
Blood Advances
|
February 15, 2024
Real-world applicability of the International Metabolic Prognostic Index in DLBCL: a validation cohort study
Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, et al.
Haematologica
|
November 30, 2023
Use of the Second Revision of the International Staging System for prognostic stratification of multiple myeloma patients in real-world clinical practice and the importance of sub-groups, including age
Yuka Uesugi, Daisuke Ikeda, Ami Fukumoto, et al.
BMC Nephrology
|
January 24, 2021
Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
Takafumi Tsushima, Tomo Suzuki, Toshiki Terao, et al.
Cancer
|
July 3, 2010
Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma
Kosei Matsue, Shun-ichi Kimura, Yoko Takanashi, et al.
European Journal of Haematology
|
April 16, 2013
Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12
Yuhki Nishida, Kengo Takeuchi, Kenji Tsuda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
January 22, 2008
[Primary amyloidosis associated with IgD-lambda M-proteinemia]
Shunichi Kimura, Ryota Iwatsuka, Takatoshi Aoki, et al.
Scientific Reports
|
July 23, 2021
Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria
Kentaro Narita, Daisuke Miura, Takafumi Tsushima, et al.
British Journal of Haematology
|
April 8, 2020
Pre-treatment metabolic tumour volume and total lesion glycolysis are superior to conventional positron-emission tomography/computed tomography variables for outcome prediction in patients with newly diagnosed multiple myeloma in clinical practice
Toshiki Terao, Youichi Machida, Takafumi Tsushima, et al.
British Journal of Haematology
|
March 22, 2021
Safety and efficacy of daratumumab in patients with multiple myeloma and severe renal failure
Ayumi Kuzume, Rikako Tabata, Toshiki Terao, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 118) with videos related to
Sort By:
Page
of 12
Leukemia & Lymphoma
|
October 8, 2025
Clinical and radiological prediction models for random skin biopsy positivity in suspected intravascular large B-cell lymphoma: development and internal validation
Hajime Sakuma, Kentaro Narita, Rikako Tabata, et al.
Blood Advances
|
February 15, 2024
Real-world applicability of the International Metabolic Prognostic Index in DLBCL: a validation cohort study
Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, et al.
Haematologica
|
November 30, 2023
Use of the Second Revision of the International Staging System for prognostic stratification of multiple myeloma patients in real-world clinical practice and the importance of sub-groups, including age
Yuka Uesugi, Daisuke Ikeda, Ami Fukumoto, et al.
BMC Nephrology
|
January 24, 2021
Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
Takafumi Tsushima, Tomo Suzuki, Toshiki Terao, et al.
Cancer
|
July 3, 2010
Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma
Kosei Matsue, Shun-ichi Kimura, Yoko Takanashi, et al.
European Journal of Haematology
|
April 16, 2013
Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12
Yuhki Nishida, Kengo Takeuchi, Kenji Tsuda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
January 22, 2008
[Primary amyloidosis associated with IgD-lambda M-proteinemia]
Shunichi Kimura, Ryota Iwatsuka, Takatoshi Aoki, et al.
Scientific Reports
|
July 23, 2021
Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria
Kentaro Narita, Daisuke Miura, Takafumi Tsushima, et al.
British Journal of Haematology
|
April 8, 2020
Pre-treatment metabolic tumour volume and total lesion glycolysis are superior to conventional positron-emission tomography/computed tomography variables for outcome prediction in patients with newly diagnosed multiple myeloma in clinical practice
Toshiki Terao, Youichi Machida, Takafumi Tsushima, et al.
British Journal of Haematology
|
March 22, 2021
Safety and efficacy of daratumumab in patients with multiple myeloma and severe renal failure
Ayumi Kuzume, Rikako Tabata, Toshiki Terao, et al.
Page
of 12